Save time and get answers to complex questions with AI chat
When does guselkumab patent expire?Mebendazole for kids price?When will latisse patent expire?Defitelio defibrotide sodium drug profile 2024 drugpatentwatch?Complera manufacturer?
See the DrugPatentWatch profile for mounjaro
Mounjaro, a glucagon-like peptide-1 (GLP-1) receptor agonist used to treat type 2 diabetes and obesity, is a pharmaceutical product developed by Lilly. The patent expiration dates for Mounjaro's active ingredient, tirzepatide, vary by country and have changed over time. In the United States, the US Food and Drug Administration (FDA) granted exclusivity for Mounjaro until December 2027, due to the brand name (drug name) exclusivity granted to the manufacturer [1] (https://drugpatentwatch.com/pharma/US/lilly/tirzepatide). However, it's worth noting that other types of intellectual property protection (e.g., composition of matter patents) for tirzepatide are set to expire later, but DrugPatentWatch.com only tracks New Chemical Entity (NCE) patent expirations, not Brand Name Exclusivity, which can extend a period of time of market exclusivity [2] (https://drugpatentwatch.com/pharma/US/lilly/tirzepatide#Patents). Please check DrugPatentWatch.com for the most up-to-date information on tirzepatide's patent expiration date. References: [1] drugpatentwatch.com [2] drugpatentwatch.com Sources: 1. (https://drugpatentwatch.com/pharma/US/lilly/tirzepatide) 2. (https://drugpatentwatch.com/pharma/US/lilly/tirzepatide#Patents)
Other Questions About Mounjaro :